The characterization was repeated with cell populations extracted from DMD patient biopsies (Figure4B), focusing on the most discriminating markers identified earlier (CD9, CD10, CD31, CD36, CD49c, CD49e, CD49f, CD140b, CD146, and CD184). This evidence concerns the gene CD9 and Duchenne muscular dystrophy.